Fexapotide - CAS 492447-54-8

Fexapotide (NX-1207 free acid) selectively induces apoptosis to effectively reduce prostate volume at the cellular level and is applicable in the research of lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) [1][2][3].

Apoptosis

Apoptosis

492385

C90H163N27O25S

2055.49

[C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H]([C@H](CC)C)N)=O)CC(O)=O)=O)CCC(N)=O)=O)CCC(N)=O)=O)C(C)C)=O)CC(C)C)=O)CO)=O)CCCNC(=N)N)=O)[C@H](CC)C)=O)(C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC(C)C)C(O)=O)=O)CS)=O)CCCNC(=N)N)=O)CCCCN)=O)[C@H](CC)C)=O)CCC(O)=O)=O)CC(C)C)=O)CCCCN

-20°C

Ice Packs

Peptide